1106821

Regeneron Pharmaceuticals Inc — FEI 1000514603

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 18, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rensselaer, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed